OTCMKTS:CRLBF Cresco Labs (CRLBF) Stock Price, News & Analysis $0.67 -0.04 (-5.31%) As of 04/2/2025 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort InterestBuy This Stock About Cresco Labs Stock (OTCMKTS:CRLBF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cresco Labs alerts:Sign Up Key Stats Today's Range$0.65▼$0.7050-Day Range$0.67▼$1.1352-Week Range$0.52▼$2.60Volume250,540 shsAverage Volume691,030 shsMarket Capitalization$324.61 millionP/E RatioN/ADividend YieldN/APrice Target$3.00Consensus RatingBuy Company OverviewCresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.Read More… Remove Ads Cresco Labs Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks53rd Percentile Overall ScoreCRLBF MarketRank™: Cresco Labs scored higher than 53% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingCresco Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageCresco Labs has only been the subject of 1 research reports in the past 90 days.Read more about Cresco Labs' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Cresco Labs are expected to grow in the coming year, from ($0.20) to ($0.05) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cresco Labs is -3.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cresco Labs is -3.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCresco Labs has a P/B Ratio of 0.54. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Cresco Labs' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.18% of the float of Cresco Labs has been sold short.Short Interest Ratio / Days to CoverCresco Labs has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cresco Labs has recently increased by 87.23%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCresco Labs does not currently pay a dividend.Dividend GrowthCresco Labs does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.18% of the float of Cresco Labs has been sold short.Short Interest Ratio / Days to CoverCresco Labs has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cresco Labs has recently increased by 87.23%, indicating that investor sentiment is decreasing significantly. News and Social Media3.0 / 5News SentimentN/A News SentimentCresco Labs has a news sentiment score of 1.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Cresco Labs this week, compared to 1 article on an average week.MarketBeat Follows6 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cresco Labs insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.05% of the stock of Cresco Labs is held by institutions.Read more about Cresco Labs' insider trading history. Receive CRLBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address CRLBF Stock News HeadlinesCresco Labs price target lowered to C$3.25 from C$3.50 at Alliance Global PartnersMarch 12, 2025 | markets.businessinsider.comCresco Labs price target lowered to C$3.25 from C$3.50 at Alliance Global PartnersMarch 12, 2025 | markets.businessinsider.comNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America. April 3, 2025 | Paradigm Press (Ad)Cresco Labs price target lowered to C$3.25 from C$3.50 at Alliance GlobalMarch 12, 2025 | markets.businessinsider.comCresco Labs price target lowered to C$3.25 from C$3.50 at Alliance GlobalMarch 12, 2025 | markets.businessinsider.comCresco Labs Inc. (CRLBF) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | seekingalpha.comCresco Labs to Operate Kentucky’s Largest Medical Cannabis Cultivation LicenseMarch 10, 2025 | financialpost.comCresco Labs to Report Fourth Quarter 2024 Financial Results on March 12, 2025March 3, 2025 | financialpost.comSee More Headlines CRLBF Stock Analysis - Frequently Asked Questions How have CRLBF shares performed this year? Cresco Labs' stock was trading at $0.9137 at the beginning of 2025. Since then, CRLBF shares have decreased by 27.2% and is now trading at $0.6650. View the best growth stocks for 2025 here. How were Cresco Labs' earnings last quarter? Cresco Labs Inc. (OTCMKTS:CRLBF) posted its quarterly earnings data on Friday, March, 14th. The company reported ($0.01) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.01). The firm earned $176 million during the quarter, compared to analysts' expectations of $172.10 million. Cresco Labs had a negative trailing twelve-month return on equity of 16.52% and a negative net margin of 9.15%. How do I buy shares of Cresco Labs? Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings3/14/2025Today4/03/2025Next Earnings (Estimated)5/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CRLBF CIK1832928 Webwww.crescolabs.com Phone312-929-0993FaxN/AEmployees3,500Year FoundedN/APrice Target and Rating Average Stock Price Target$3.00 High Stock Price Target$3.00 Low Stock Price Target$3.00 Potential Upside/Downside+351.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($0.22) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-175,520,000.00 Net Margins-9.15% Pretax Margin-0.12% Return on Equity-16.52% Return on Assets-4.81% Debt Debt-to-Equity Ratio1.80 Current Ratio1.97 Quick Ratio1.39 Sales & Book Value Annual Sales$770.89 million Price / Sales0.42 Cash Flow$0.04 per share Price / Cash Flow18.48 Book Value$1.24 per share Price / Book0.54Miscellaneous Outstanding Shares488,140,000Free FloatN/AMarket Cap$324.61 million OptionableNot Optionable Beta1.79 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (OTCMKTS:CRLBF) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cresco Labs Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cresco Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.